Want to join the conversation?
$KIM 2Q15 Call: FFO as adjusted, which excludes non-operating impairments and transactional income and expense was $0.37 per diluted share for the second quarter of 2015, up from $0.35 last year, reflecting a 5.7% increase over the same period in 2014.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.